{"nct_id":"NCT04392154","title":"Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)","status":"COMPLETED","status_verified_date":"2025-07","start_date":"2020-06-15","start_date_type":"ACTUAL","primary_completion_date":"2024-07-19","primary_completion_date_type":"ACTUAL","completion_date":"2025-04-22","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["LLY"]}